Golgi retention of KIT in gastrointestinal stromal tumour cells is phospholipase D activity-dependent
Abstract A constitutively active mutant of the receptor protein tyrosine kinase KIT is a major cause of gastrointestinal stromal tumours (GISTs). Recently, we discovered that, during biosynthetic transport, the KIT mutant (KITmut) is retained in the Golgi/trans-Golgi network (TGN), where it activate...
Saved in:
| Main Authors: | Yuuki Obata, Miyuki Natsume, Isamu Shiina, Tsuyoshi Takahashi, Toshirou Nishida |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-14739-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Surgery for multiple gastric gastrointestinal stromal tumors and large esophageal diverticulum related to germline mutation of the KIT gene: a case report
by: Asami Arita, et al.
Published: (2023-10-01) -
A Canine <i>c-kit</i> Novel Mutation Isolated from a Gastrointestinal Stromal Tumor (GIST) Retains the Ability to Form Dimers but Lacks Autophosphorylation
by: Kei Shimakawa, et al.
Published: (2025-05-01) -
Advances in Small-Molecule C-KIT/PDGFRα Inhibitors for the Treatment of Gastrointestinal Stromal Tumors
by: Xuan Zheng, et al.
Published: (2024-12-01) -
miRNA‐221 and miRNA‐222 induce apoptosis via the KIT/AKT signalling pathway in gastrointestinal stromal tumours
by: Michaela Angelika Ihle, et al.
Published: (2015-08-01) -
SOCS2 inhibits the tumorigenesis of GISTs and increases the sensitivity of GISTs to imatinib by suppression of KIT activation
by: Liangying Zhang, et al.
Published: (2025-02-01)